ATRION/ATRI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ATRION

Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Ticker

ATRI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Emile Battat

Employees

712

Headquarters

Allen, United States

ATRION Metrics

BasicAdvanced
$810M
Market cap
43.28
P/E ratio
$10.63
EPS
0.66
Beta
$8.75
Dividend rate
1.91%
Dividend yield
$810M
0.66471
$602.59
$274.98
31K
$8.75
9.183
3.062
82.45%
889.027
7.20%
7.79%
7.63%
43.282
4.585
3.348
3.504
1.21%
1.90%
1.91%
0.17%
-36.76%
4.69%
-14.19%
9.65%

ATRION Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
5.70% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$47M
8.74%
Net income
$2.7M
-57.81%
Profit margin
5.70%
-61.25%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

Jun
28
ATRION
Dividend·Payment
$2.20
Per share

FAQs

What’s the current market cap for ATRION stock?

ATRION (ATRI) has a market cap of $810M as of June 15, 2024.

What is the P/E ratio for ATRION stock?

The price to earnings (P/E) ratio for ATRION (ATRI) stock is 43.28 as of June 15, 2024.

Does ATRION stock pay dividends?

Yes, the ATRION (ATRI) stock pays dividends to shareholders. As of June 15, 2024, the dividend rate is $8.75 and the yield is 1.91%. ATRION has a payout ratio of 82.45% on a trailing twelve-month basis.

When is the next ATRION dividend payment date?

The next ATRION (ATRI) dividend payment is scheduled for June 28, 2024.

What is the beta indicator for ATRION?

ATRION (ATRI) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the ATRION stock price target?

The target price for ATRION (ATRI) stock is $, which is NaN% below the current price of $. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell ATRION stock

Buy or sell ATRION stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing